key: cord-0932864-zfxr31b9 authors: Diep, Phuoc-Tan; de Kok, Véronique title: Could oxytocin reduce autoimmune disease in COVID-19? date: 2021-11-16 journal: Autoimmun Rev DOI: 10.1016/j.autrev.2021.102994 sha: 10ef3f61d58a4d13a9328aa55d0f8c1ff4848281 doc_id: 932864 cord_uid: zfxr31b9 Disruption of immune and neuroendocrine system function has been shown to play a key role in COVID-19. Oxytocin is vitally important for the immune and neuroendocrine systems. However, oxytocin dysfunction might occur in COVID-19 leading to autoimmune disease. Intranasal oxytocin may be effective in turning off an overactive immune system. This could be a powerful approach to avoid possible autoimmune diseases after COVID-19. KEYWORDS : COVID-19 ; Oxytocin ; hypothalamus ; Immune-neuroendocrine system ; Autoimmune diseases ; Intranasal administration Dear Editor, Jara et al. provided an excellent explanation of how the immune system and the neuroendocrine system function in regard to COVID-19 and autoimmunity [1] . However, we would like to highlight an overlooked part of the hypothalamic-pituitary axis: oxytocin. It is a neurohormone produced in the hypothalamus and secreted from the posterior pituitary gland and it is of vital importance to the immune and neuroendocrine systems [2] . Indeed, it has been shown that oxytocin can suppress the up-regulation of toll-like receptor 4 (TLR4) [3] ; suppress the release of interleukin 6 (IL-6) [4, 5] , tumor necrosis factor alpha (TNF-alpha) [5] ; inhibit the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway [6] ; increase FOXP3+ regulatory T cells [7] , modulate neutrophils [8] , mast cells [9] and macrophages [10] . In other words, it may be able to turn off an activated proinflammatory immune system and therefore reduce the likelihood of autoimmune disease [11] . Last, but not least, oxytocin could be a direct antiviral against SARS-CoV-2 [12] thus limiting the initial infection and subsequent inflammation. So, is it possible that SARS-CoV-2 infection disrupts oxytocin function? We believe so. Jara et al. note that the hypothalamus can be infected by SARS-CoV-2 [1] . Oxytocin neurones in the hypothalamus most probably co-express angiotensin-converting enzyme 2 (ACE2) and transmembrane protease, serine 2 (TMPRSS2) and could therefore be infected [13] . Also, the pituitary gland is not isolated from the systemic circulation by the blood brain barrier [14] and therefore could be infected haematogenously. Thus central infection could lead to a reduction in oxytocin production. Peripherally, SARS-CoV-2 infection of the vagus nerve [15] may also lead to reduced oxytocin function [7] . In addition, Liu and Conboy also showed that the oxytocin receptor J o u r n a l P r e -p r o o f can be down-regulated by viral infections [16] . Further, reduced thymic function in severe COVID-19 [17, 18] , could result in reduced immune protection for the oxytocin peptide [19] and presumably lead to the production of oxytocin autoantibodies [20] as well as a general increase in autoimmunity. Also oxytocin function decreases with age [21] . It is, therefore, a distinct possibility that oxytocin dysfunction occurs in COVID-19 and could lead to immune dysfunction and possibly to autoimmune disease. Unfortunately, to our knowledge, plasma levels of oxytocin have not been measured in COVID-19 patients. However, the oxytocin signaling pathway was reduced in the nasopharyngeal metabolome of such patients [22] . It would seem a natural step to use oxytocin to turn off, to deactivate, an over-active immune system. Intranasal oxytocin may be particularly effective as it may also stimulate endogenous release of oxytocin [23] . This may provide a powerful approach to head off autoimmune disease post COVID-19. The immune-neuroendocrine system in COVID-19, advanced age and rheumatic diseases Approaches Mediating Oxytocin Regulation of the Immune System Oxytocin ameliorates bone cancer pain by suppressing toll-like receptor 4 and proinflammatory cytokines in rat spinal cord Oxytocin attenuates NADPH-dependent superoxide activity and IL-6 secretion in macrophages and vascular cells Oxytocin alleviates the neuroendocrine and cytokine response to bacterial endotoxin in healthy men Oxytocin effects on the inhibition of the NF-κB/miR195 pathway in mice breast cancer Microbial symbionts accelerate wound healing via the neuropeptide hormone oxytocin Oxytocin protects against sepsis-induced multiple organ damage: role of neutrophils The antinociception of oxytocin on colonic hypersensitivity in rats was mediated by inhibition of mast cell degranulation via Ca(2+)-NOS pathway Oxytocin system alleviates intestinal inflammation by regulating macrophages polarization in experimental colitis Autoimmune Disease: Mechanisms. eLS Hypothesis: Oxytocin is a direct COVID-19 antiviral Is there an underlying link between COVID-19, ACE2, oxytocin and vitamin D? Endocrinology: An Integrated Approach Vagus nerve neuropathy related to SARS COV-2 infection. IDCases, 26, e01242 Unexpected evolutionarily conserved rapid effects of viral infection on oxytocin receptor and TGF-β/pSmad3 Potential impact of SARS-CoV-2 infection on the thymus The role of the thymus in COVID-19 disease severity: implications for antibody treatment and immunization The presentation of neuroendocrine self-peptides in the thymus: an essential event for individual life and vertebrate survival Autoantibodies reacting with vasopressin and oxytocin in relation to cortisol secretion in mild and moderate depression Oxytocin is an age-specific circulating hormone that is necessary for muscle maintenance and regeneration Association between the nasopharyngeal microbiome and metabolome in patients with COVID-19 Evidence for intranasal oxytocin delivery to the brain: recent advances and future perspectives